Voxeleron announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $222,991 from the National Institutes of Health’s (NIH) National Center for the Advancement of Translational Sciences (NCATS), to further develop device-independent retinal…
We are pleased to report that our abstract, "Deep convolutional neural networks for automated OCT pathology recognition" was accepted for presentation at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). The research was performed…
Voxeleron is pleased to announce the acceptance of our submission Comparison of Automated Retinal Segmentation across OCT Devices using Independent Analysis Software to the scientific sessions of the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO 2016)…
Researchers in Barcelona at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) recently used OrionTM to demonstrate inner retinal biomarkers for prediction of visual function loss in non-arteritic ischaemic optic neuropathy. For more information please see the paper or the…
We are very excited to announce the release of Orion, our advanced OCT analysis software. For more information, please visit: https://voxeleron.com/orion/ or see our press release: http://www.prweb.com/releases/2015/02/prweb12513586.htm
